XML 41 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information
3 Months Ended
Mar. 31, 2012
Segment Information [Abstract]  
Segment Information

11. Segment Information

The company's management considers its business to be a single segment entity—the manufacture and sale of medical devices. The company's products generally share similar distribution channels and customers. The company designs, develops, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices. The company sells a broad range of products to hospitals, individual healthcare professionals, extended care health facilities and alternate site facilities on a global basis. In general, the company's products are intended to be used once and then discarded or either temporarily or permanently implanted. The company's chief operating decision makers evaluate their various global product portfolios on a net sales basis and generally evaluate profitability and associated investment on an enterprise-wide basis due to shared geographic infrastructures.

 

Net sales based on the location of external customers by geographic region are:

 

     Three Months Ended
March 31,
 
     2012      2011  
(dollars in millions)       

United States

   $ 496.2       $ 487.1   

Europe

     122.8         118.1   

Japan

     39.1         32.8   

Other

     71.9         62.3   
  

 

 

    

 

 

 
   $ 730.0       $ 700.3   
  

 

 

    

 

 

 

 

Total net sales by product group category are:

 

 

 

     Three Months Ended
March 31,
 
     2012      2011  
(dollars in millions)       

Vascular

   $ 209.2       $ 198.3   

Urology

     185.1         179.5   

Oncology

     198.9         186.4   

Surgical Specialties

     114.7         114.9   

Other

     22.1         21.2   
  

 

 

    

 

 

 
   $ 730.0       $ 700.3   
  

 

 

    

 

 

 

 

Other information is:

 

 

 

     Three Months Ended
March 31,
 
     2012      2011  
(dollars in millions)       

Depreciation

   $ 13.1       $ 13.3   
  

 

 

    

 

 

 

Amortization

   $ 20.3       $ 14.9